Back
Keros Therapeutics Stock Price Chart
Sponsored
KROS
Sponsored
Today's Fastest Growing Company Might Surprise You
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
14
KROS
Keros Therapeutics
Last Price:
$16.07
Seasonality Move:
10.52%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Dreams, Mode Mobile Delivers
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.
Keros Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 16.32 | Sell |
20-day SMA: | 29.65 | Sell |
50-day SMA: | 47.91 | Sell |
200-day SMA: | 51.84 | Sell |
8-day EMA: | 17.43 | Sell |
20-day EMA: | 26.94 | Sell |
50-day EMA: | 40.66 | Sell |
200-day EMA: | 49.17 | Sell |
Keros Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -10.67 | Sell |
Relative Strength Index (14 RSI): | 23.11 | Sell |
Chaikin Money Flow: | -61494 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.67 - 59.01) | Sell |
Bollinger Bands (100): | (35.52 - 66.42) | Sell |
Keros Therapeutics Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Keros Therapeutics Stock
Is Keros Therapeutics Stock a Buy?
-
Keros Therapeutics share price is 16.10 while KROS 8-day simple moving average is 16.32, which is a Sell signal.
-
The stock price of KROS is 16.10 while Keros Therapeutics 20-day SMA is 29.65, which makes it a Sell.
-
Keros Therapeutics 50-day simple moving average is 47.91 while KROS share price is 16.10, making it a Sell technically.
-
KROS stock price is 16.10 and Keros Therapeutics 200-day simple moving average is 51.84, creating a Sell signal.
KROS Technical Analysis vs Fundamental Analysis
Sell
14
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy or a Sell?
-
Keros Therapeutics stock is rated a SellThe current Keros Therapeutics [KROS] share price is $16.10. The Score for KROS is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
Keros Therapeutics Stock Info
Market Cap:
652.2M
Price in USD:
16.10
Share Volume:
750.1K
Keros Therapeutics 52-Week Range
52-Week High:
73.00
52-Week Low:
15.33
Sell
14
Keros Therapeutics (KROS)
is a Sell
Keros Therapeutics Share Price Forecast
-
What is the Keros Therapeutics stock price today?The Keros Therapeutics stock price is 16.10 USD today.
-
Will KROS stock go up or go down?Keros Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Keros Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Keros Therapeutics is overvalued.
Is Keros Therapeutics Stock a Buy?
-
Keros Therapeutics share price is 16.10 while KROS 8-day exponential moving average is 17.43, which is a Sell signal.
-
The stock price of KROS is 16.10 while Keros Therapeutics 20-day EMA is 26.94, which makes it a Sell.
-
Keros Therapeutics 50-day exponential moving average is 40.66 while KROS share price is 16.10, making it a Sell technically.
-
KROS stock price is 16.10 and Keros Therapeutics 200-day simple moving average is 49.17, creating a Sell signal.
Fundamental Analysis of Keros Therapeutics
Is Keros Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.82 per share.
Technical Analysis of Keros Therapeutics
Should I short Keros Therapeutics stock?
-
KROS Moving Average Covergence Divergence (MACD) indicator is -10.67, suggesting Keros Therapeutics is a Sell
-
Keros Therapeutics Relative Strength Index (RSI) is 23.11, which suggest Keros Therapeutics is oversold
-
The Bollinger Bands (25) for Keros Therapeutics is (12.67 - 59.01), which suggest Keros Therapeutics is a Sell
-
The Bollinger Bands (100) for Keros Therapeutics is (35.52 - 66.42), which suggest Keros Therapeutics is a Sell
* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.